Showing results (71-80 of 6,269) with videos related to

Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|February 24, 2011
Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeksA Pfützner, E Paz-Pacheco, E Allen, et al.
Diabetes, Obesity & Metabolism|February 22, 2011
Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairmentM Nowicki, I Rychlik, H Haller, et al.
Diabetes, Obesity & Metabolism|May 11, 2011
Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetesR R Henry, S R Smith, S L Schwartz, et al.
Diabetes, Obesity & Metabolism|May 4, 2011
New approaches to the treatment of diabetic retinopathyM Porta, P Maldari, F Mazzaglia
Diabetes, Obesity & Metabolism|March 18, 2011
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargineG P Fadini, S V de Kreutzenberg, V Mariano, et al.
Diabetes, Obesity & Metabolism|March 26, 2011
Rotational co-culture of clonal β-cells with endothelial cells: effect of PPAR-γ agonism in vitro on insulin and VEGF secretionM B Paget, H E Murray, C J Bailey, et al.
Diabetes, Obesity & Metabolism|March 2, 2021
MRI measures of hypothalamic injury are associated with glucagon-like peptide-1 receptor agonist treatment response in people with hypothalamic obesityFrancisco A Perez, Clinton Elfers, Jack A Yanovski, et al.
Diabetes, Obesity & Metabolism|March 2, 2021
Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United StatesKarine Suissa, Sebastian Schneeweiss, Dong Wook Kim, et al.
Diabetes, Obesity & Metabolism|March 25, 2021
Cardiovascular effects of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: The P value and beyondDavid E Kloecker, Melanie J Davies, Kamlesh Khunti, et al.
Diabetes, Obesity & Metabolism|March 25, 2021
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock studyLuca D'Onofrio, Silvia Pieralice, Ernesto Maddaloni, et al.
Pageof 627